Eaton Vance Management’s Anika Therapeutics ANIK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-217
| Closed | -$8K | – | 1845 |
|
|
2021
Q4 | $8K | Sell |
217
-8
| -4% | -$295 | ﹤0.01% | 2566 |
|
|
2021
Q3 | $0 | Sell |
225
-109
| -33% | – | ﹤0.01% | 2015 |
|
|
2021
Q2 | $15K | Buy |
334
+269
| +414% | +$12.1K | ﹤0.01% | 2476 |
|
|
2021
Q1 | $3K | Sell |
65
-5,290
| -99% | -$244K | ﹤0.01% | 2688 |
|
|
2020
Q4 | $242K | Buy |
+5,355
| New | +$242K | ﹤0.01% | 1378 |
|
|
2018
Q4 | – | Sell |
-5,732
| Closed | -$242K | – | 1176 |
|
|
2018
Q3 | $242K | Buy |
+5,732
| New | +$242K | ﹤0.01% | 1154 |
|
|
2018
Q2 | – | Sell |
-11,464
| Closed | -$570K | – | 1173 |
|
|
2018
Q1 | $570K | Buy |
11,464
+5,732
| +100% | +$285K | ﹤0.01% | 1073 |
|
|
2017
Q4 | $309K | Buy |
5,732
+4
| +0.1% | +$216 | ﹤0.01% | 1046 |
|
|
2017
Q3 | $332K | Buy |
5,728
+2
| +0% | +$116 | ﹤0.01% | 1012 |
|
|
2017
Q2 | $283K | Buy |
5,726
+8
| +0.1% | +$395 | ﹤0.01% | 1015 |
|
|
2017
Q1 | $248K | Sell |
5,718
-295
| -5% | -$12.8K | ﹤0.01% | 993 |
|
|
2016
Q4 | $294K | Hold |
6,013
| – | – | ﹤0.01% | 941 |
|
|
2016
Q3 | $288K | Hold |
6,013
| – | – | ﹤0.01% | 920 |
|
|
2016
Q2 | $323K | Sell |
6,013
-2,000
| -25% | -$107K | ﹤0.01% | 878 |
|
|
2016
Q1 | $358K | Hold |
8,013
| – | – | ﹤0.01% | 842 |
|
|
2015
Q4 | $306K | Sell |
8,013
-2,002
| -20% | -$76.5K | ﹤0.01% | 868 |
|
|
2015
Q3 | $319K | Hold |
10,015
| – | – | ﹤0.01% | 852 |
|
|
2015
Q2 | $331K | Hold |
10,015
| – | – | ﹤0.01% | 828 |
|
|
2015
Q1 | $412K | Buy |
+10,015
| New | +$412K | ﹤0.01% | 825 |
|